PrimeRFP SCOUT · Federal Contract Profile

Alvogen (LJNNGDV77Y98)Federal contracts · 2 recompetes

Alvogen holds $284.8M in federal volume across 11 award actions, with 100% at Department of Health and Human Services (HHS). SCOUT tracks 2 incumbent recompetes — an estimated $302.2M returning to market over the next 24 months (High exposure). Primary work: Pharmaceutical Preparation (100% prime). Obligations are up 299% year over year.

$284.8M

Federal Volume

Recompetes (24mo)

HHS

Top Agency · 100% firm-wide

11

Award Actions

Choose one — this changes what we ask next

Score my firm against Alvogen

Email me when a Alvogen recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS

Where they win

Sole agency

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$284.8M · 100% of firm total

Recompete exposure: High · 2 in 24mo

Alvogen has an estimated $302.2M in contracts returning to market over the next 24 months.

Part of the AON CONSULTING INC corporate family · 2 entities

Metrics basis: local_db

Who buys from them

Agency buyer map

1 buyers

Department of Health and Human Services (HHS)6 awards · repeat buyer · $284.8M

Recompete exposure & trajectory

Recompete exposure

High

Alvogen has an estimated $302.2M in contracts returning to market over the next 24 months.

OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 47781-470-13); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 47781-468-13); →

PIID: 75A50325F80013 · Expires 2027-06-29

$227.7M

OSELTAMIVIR PHOSPHATE 75MG, 10 CT BLISTER (ADULT COURSE) →

PIID: 75A50324F63003 · Expires 2027-09-28

$74.5M

Trajectory

▲ Expanding+299% YoYFY2025 vs FY2024

'23

'24

'25

“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”

— Shauna Weatherly, FedSubK

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Alvogen hold?

Alvogen (UEI LJNNGDV77Y98) shows $284.8M across 11 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Alvogen have?

Alvogen shows $284.8M across 11 award actions. SCOUT tracks 2 incumbent recompetes ($302.2M) returning to market in the next 24 months.

Which agencies does Alvogen work with?

Alvogen’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%).

What is the UEI for Alvogen?

The Unique Entity ID (UEI) for Alvogen is LJNNGDV77Y98.

Does Alvogen have contracts coming up for recompete?

Yes — SCOUT tracks 2 incumbent recompetes in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.